Rare diseases
Investigational molecules
Locations
Haifa-Allee 24, Bretzenheim, 55128 Mainz, Germany
IKF Pneumologie GmbH & Co. KG in Mainz, Germany specialises in clinical trials of conditions such as Asthma, Chronic obstructive pulmonary disease, Obesity, Overweight, and other specialisations. This site conducts important research.
Clinical trials currently enrolling participants at this site.
Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
GermanyA Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
GermanyStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
GermanyStudy of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
GermanyEfficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations
GermanyEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
GermanyA study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.
GermanyComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
GermanyA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
GermanyTesting WIN378 Safety and Effects in Adults with Moderate or Severe Asthma
GermanyStudy of depemokimab to improve airway function in patients with type 2 eosinophilic asthma
GermanyStudy of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease
GermanyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
